Evidence map›Paper›PMID 31477117›Full record

Trial reportMalaria journal2019

Microscopic and submicroscopic Plasmodium falciparum infection, maternal anaemia and adverse pregnancy outcomes in Papua New Guinea: a cohort study.

Holger W Unger, Anna Rosanas-Urgell, Leanne J Robinson, Maria Ome-Kaius, Shadrach Jally, Alexandra J Umbers, Willie Pomat, Ivo Mueller, Eline Kattenberg, Stephen J Rogerson

Open access · goldAbstract readClinical Trial
In one paragraph

Trial report in Malaria journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Asymptomatic/submicroscopicParasite epidemiology and control · 2025
    Article
  4. Current update on malaria in pregnancy: a systematic review.Tropical diseases, travel medicine and vaccines · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 5 countries.

Holger W UngerCentre for Maternal and Newborn Health, Liverpool School of Tropical Medicine, Liverpool, UK.
Anna Rosanas-UrgellInstitute of Tropical Medicine, Antwerp, Belgium.
Leanne J RobinsonVector Borne Diseases Unit, PNG Institute of Medical Research, Goroka, Papua New Guinea.
Maria Ome-KaiusVector Borne Diseases Unit, PNG Institute of Medical Research, Goroka, Papua New Guinea.
Shadrach JallyVector Borne Diseases Unit, PNG Institute of Medical Research, Goroka, Papua New Guinea.
Alexandra J UmbersBurnet Institute, Melbourne, Australia.
Willie PomatVector Borne Diseases Unit, PNG Institute of Medical Research, Goroka, Papua New Guinea.
Ivo MuellerWalter and Eliza Hall Institute of Medical Research, Parkville, Australia.
Eline KattenbergInstitute of Tropical Medicine, Antwerp, Belgium.
Stephen J RogersonDepartment of Medicine, (RMH), Peter Doherty Institute for Infection and Immunity, The University of Melbourne, 792 Elizabeth Street, Melbourne, VIC, 3000, Australia. sroger@unimelb.edu.au.ORCID http://orcid.org/0000-0003-4287-1982
Burnet Institute · AUInstituut voor Tropische Geneeskunde · BEPapua New Guinea Institute of Medical Research · PGInstitut Pasteur · FRLiverpool School of Tropical Medicine · GBThe University of Melbourne · AUWalter and Eliza Hall Institute of Medical Research · AU

Funding

Bill and Melinda Gates Foundation 46099European Union FP7-2007-HealthPfizer Inc WS394663
6 · The paper itself

Abstract

backgroundInfection during pregnancy with Plasmodium falciparum is associated with maternal anaemia and adverse birth outcomes including low birth weight (LBW). Studies using polymerase chain reaction (PCR) techniques indicate that at least half of all infections in maternal venous blood are missed by light microscopy or rapid diagnostic tests. The impact of these subpatent infections on maternal and birth outcomes remains unclear.

methodsIn a cohort of women co-enrolled in a clinical trial of intermittent treatment with sulfadoxine-pyrimethamine (SP) plus azithromycin for the prevention of LBW (< 2500 g) in Papua New Guinea (PNG), P. falciparum infection status at antenatal enrolment and delivery was assessed by routine light microscopy and real-time quantitative PCR. The impact of infection status at enrolment and delivery on adverse birth outcomes and maternal haemoglobin at delivery was assessed using logistic and linear regression models adjusting for potential confounders. Together with insecticide-treated bed nets, women had received up to 3 monthly intermittent preventive treatments with SP plus azithromycin or a single clearance treatment with SP plus chloroquine.

resultsA total of 9.8% (214/2190) of women had P. falciparum (mono-infection or mixed infection with Plasmodium vivax) detected in venous blood at antenatal enrolment at 14-26 weeks' gestation. 4.7% of women had microscopic, and 5.1% submicroscopic P. falciparum infection. At delivery (n = 1936), 1.5% and 2.0% of women had submicroscopic and microscopic P. falciparum detected in peripheral blood, respectively. Submicroscopic P. falciparum infections at enrolment or at delivery in peripheral or placental blood were not associated with maternal anaemia or adverse birth outcomes such as LBW. Microscopic P. falciparum infection at antenatal enrolment was associated with anaemia at delivery (adjusted odds ratio [aOR] 2.00, 95% confidence interval [CI] 1.09, 3.67; P = 0.025). Peripheral microscopic P. falciparum infection at delivery was associated with LBW (aOR 2.75, 95% CI 1.27; 5.94, P = 0.010) and preterm birth (aOR 6.58, 95% CI 2.46, 17.62; P < 0.001).

conclusionsA substantial proportion of P. falciparum infections in pregnant women in PNG were submicroscopic. Microscopic, but not submicroscopic, infections were associated with adverse outcomes in women receiving malaria preventive treatment and insecticide-treated bed nets. Current malaria prevention policies that combine insecticide-treated bed nets, intermittent preventive treatment and prompt treatment of symptomatic infections appear to be appropriate for the management of malaria in pregnancy in settings like PNG.

Indexed as

Infant, Low Birth WeightAdultAnemiaAnti-Bacterial AgentsAntimalarialsArtemisininsAsymptomatic InfectionsAzithromycinFemaleHemoglobin AHumansInfant, NewbornMalaria, FalciparumPapua New GuineaPlasmodium falciparumPregnancyAnti-Bacterial AgentsAntimalarialsArtemisininsAzithromycinHemoglobin APyrimethamineSulfadoxinesulfadoxine-pyrimethamine-artesunateAnaemiaDiagnosisFetal growth retardationLow birth weightMalariaPlasmodium falciparumPregnancy outcomePremature birth

Identifiers

PMID31477117
PMCPMC6720091
OpenAlexW2971982312

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.